Muntean, C.; Solomon, A.; Cipaian, R.C.; Vonica, R.C.; Butuca, A.; Gaborean, V.; Faur, I.F.; Feier, C.V.I.
The Efficacy and Safety of Anlotinib in the Treatment of Thyroid Cancer: A Systematic Review. J. Clin. Med. 2025, 14, 338.
https://doi.org/10.3390/jcm14020338
AMA Style
Muntean C, Solomon A, Cipaian RC, Vonica RC, Butuca A, Gaborean V, Faur IF, Feier CVI.
The Efficacy and Safety of Anlotinib in the Treatment of Thyroid Cancer: A Systematic Review. Journal of Clinical Medicine. 2025; 14(2):338.
https://doi.org/10.3390/jcm14020338
Chicago/Turabian Style
Muntean, Calin, Adelaida Solomon, Remus Calin Cipaian, Razvan Constantin Vonica, Anca Butuca, Vasile Gaborean, Ionut Flaviu Faur, and Catalin Vladut Ionut Feier.
2025. "The Efficacy and Safety of Anlotinib in the Treatment of Thyroid Cancer: A Systematic Review" Journal of Clinical Medicine 14, no. 2: 338.
https://doi.org/10.3390/jcm14020338
APA Style
Muntean, C., Solomon, A., Cipaian, R. C., Vonica, R. C., Butuca, A., Gaborean, V., Faur, I. F., & Feier, C. V. I.
(2025). The Efficacy and Safety of Anlotinib in the Treatment of Thyroid Cancer: A Systematic Review. Journal of Clinical Medicine, 14(2), 338.
https://doi.org/10.3390/jcm14020338
